We surveyed hospital patients and clinicians to ascertain their attitudes to the establishment of a perioperative biobank for future genomics research, and whether the requirements for an opt-out approach to consent can be met. We enrolled hospital patients (n=187), patient spouse/family members (n=64), ethics committee members (n=14), clinical staff (doctors and nurses [n=67]), and unspecified community members (n=10). They were asked to rate and describe their views on medical research and biobanking, the need for individual consent, and the importance of confidentiality. Of 406 survey forms distributed, 342 (84%) were returned. Nearly all participants (98%) indicated that a perioperative biobank is important, 93% were comfortable with de-identified genetic research, and 90% indicated that the hospital should be able to use leftover blood for medical research, provided the research has been approved by an ethics committee and personally identifying information has been removed. Participants were more likely to support biobanking if it used de-identified samples, and if, for this reason, their consent was not sought. Participants with chronic medical and surgical conditions were significantly more supportive and comfortable with genetic research, as were most in the hospital community. Most hospital patients, community members and clinicians are supportive of the development of a perioperative biobank used for genomic research. This supports the adoption of an opt-out approach to consent model.
Introduction
Perioperative genomics-the study of how a patient's genes affect their response and recovery after major surgery or trauma 1 -is gaining interest in this era of personalised medicine. Variation in gene expression (epigenetics) is likely to influence perioperative outcomes. Studying epigenetic variation and functional genomics (genes, protein function and interaction) and the changes that occur to these during different treatments or disease states, such as during the perioperative period, is expected to enhance our understanding and treatment options into the future 1 .
Genomic profiling could lead to better risk stratification and information regarding estimated prognosis and complication rates, different surgical treatment recommendations, and tailoring of anaesthetic management and medications. Studies have already reported genetic associations with chronic pain after surgery 2 , differences in the ability of cells to withstand hypoxia 3 , variable drug responses in the perioperative environment (such as antiplatelet drugs, beta-blockers, opioids and other analgesics) 1 and specific genetic changes (single nucleotide polymorphisms [SNPs]) associated with higher rates of stroke, renal failure and serious bleeding after cardiac and other major surgery 1 .
Hospital-based biobanks can store tissue, cross-referenced with de-identified patient demographic and clinical information regarding medical management and outcomes on a very large scale, thus providing a wealth of data for genomic research 4 . Understandably the National Health and Medical Research Council National Biobanking Strategy (2012) recognised the value of biobanks as essential tools for medical research 5 .
Research efficiency is an important ethical consideration for all medical research 6, 7 . Efforts to streamline enrolment and data collection are needed to provide value for highly competitive medical research funding. Studies have identified that an opt-out consent approach is considerably cheaper than traditional prospectively consented cohort models for large-scale research 8 . A good example is the hospital-based biobank at Vanderbilt University (Nashville, TN, USA) 4 . An opt-out approach to consent has recently been recognised by the National Health and Medical Research Council in the National Statement on Ethical Conduct in Human Research (updated 2014) as an appropriate choice for large-scale, low-risk studies in Australia, provided certain requirements are met, including "being certain that there is no known or likely reason for thinking that participants would not have consented to the research if they had been asked" 9 .
With the realistic likelihood that large, perioperative genomic biobanks may be developed in hospitals in the near future, it was considered important to survey the opinion of the wider hospital community to determine the level of comfort and support (or lack thereof) for genomic research and what factors may modify this level of support, to inform hospitals and researchers on how such a biobank might best be established, and to determine whether opt-out consent would be an appropriate approach. Results from this survey would add to previous Australian research 10 and provide updated and nationally appropriate information.
Materials and methods
This was a partially-targeted, cross-sectional survey included in a project designed to investigate the feasibility and appropriateness of developing a perioperative biobank. Ethics approval was obtained from The Alfred Hospital Human Research Ethics Committee (291/14). Data were collected between September and October 2014.
The survey instrument was modified from a questionnaire developed by Vanderbilt Medical University Center for a similar purpose 11 , with questions regarding demographics adapted to the local situation 12 . This resulted in a 28-item questionnaire consisting of discrete and free-text responses (see Appendix 1) .
A total of 406 questionnaires were distributed to potential study participants representing seven clinical and nonclinical areas of the hospital: 1. Pre-admission (outpatient) clinic (n=220)-patients being assessed for elective surgery, their spouse/family member, and clinical staff (doctors, nurses). Potential participants in the pre-admission (elective surgery) clinic were a population primarily engaged with the hospital because of current (often acute) surgical illness, whereas participants in the infectious diseases and transplant clinics were a population primarily engaged with the hospital due to chronic medical and surgical conditions, including potentially socially stigmatising conditions (such as some infectious diseases).
Anonymity was maintained by asking participants to deposit their completed forms into marked boxes in all survey areas, and for ethics committee members to return theirs via reply-paid envelopes addressed to a central research office. A research team member coded and entered all data from returned questionnaires into a computer spreadsheet. Raw responses to all freetext questions were coded to include categorising into thematic reasons for being comfortable or uncomfortable with genetic research (Question 6, see Appendix 2); if unclear, a second researcher reviewed the response and the best descriptor was then determined by consensus. Socioeconomic status was determined from the participants' residential postcode as per the Australian Bureau of Statistics Postal Area Index for Relative Socioeconomic Advantage and Disadvantage 2011 (released 2013) 13 .
Statistical analysis
Our primary analysis included the level of support and degree of comfort for both genetic research and biobank development, and any factors that modified this support. Subgroup analyses were done to examine whether certain cohorts within the wider hospital community held significantly different opinions to others. The prespecified subgroups were participants with acute versus chronic illness, clinicians versus non-clinicians, ethics committee members versus other non-clinicians, and those comfortable versus uncomfortable with participating in genetic research.
Continuous variables are presented as mean (standard deviation) if normally distributed, and median (interquartile range) for non-normal variables. Ordinal data were analysed with the Mann-Whitney U test, and categorical data with chi-square or Fisher's exact test, as appropriate. All analyses were done using SPSS for Windows v.20 (SPSS Australasia Ltd, Sydney, New South Wales). A P-value of less than 0.05 was considered statistically significant; no correction was made for multiple comparisons.
Results
Of the 406 questionnaires distributed to the various areas of the hospital, 342 (84%) were returned but it is unclear whether the 64 missing forms were not used or represent refusals ( Table 1) ; 83 of the 342 returned forms were not completed because potential participants indicated their refusal. Thus, the overall response rate was between 64% and 76%. Patients and family members, and anaesthetists and surgeons, had higher response rates when compared with ethics committee members, 86% and 77% versus 50%, respectively. Participants were mostly middle-aged and frequently from areas of high socioeconomic status. 
Primary outcomes
While only 16% of participants had prior experience of any genetic illness, testing and/or counselling themselves or within their family, 98% of participants believed that a perioperative biobank designed for genomic research is important, 93% were comfortable with biobanking de-identified samples for genetic research, and 90% believed the hospital should be able to use leftover blood for medical research provided the specific research has been approved by an ethics committee and personally identifying information has been removed ( Table 2) . Interestingly, 53% of respondents assumed that leftover blood and tissues from hospital patients might already be used for research.
Common reasons for this comfort and support were an altruistic desire to help others, a desire to improve medical knowledge, and a general willingness and lack of any concerns to contribute to genetic research (Table 3) . However, it should be noted that 20% of respondents who indicated feeling somewhat or very comfortable with genetic research clarified in their free-text responses that this was conditional upon certain requirements being met, primarily that de-identification, health information privacy, data security and research ethics and governance were ensured.
Modifying factors
Factors that enhanced participants' support for biobanking and genetic research included whether the data record did not contain identifying information, if the research was addressing surgical conditions or affecting people who had sustained trauma, and if the research was investigating ways for people to avoid potentially harmful treatments or procedures.
Participants were somewhat more likely to support a biobank where written consent was not sought beforehand if it were to improve privacy.
Participant subgroups
Participants with chronic illness versus acute illness Those with chronic conditions (surveyed in infectious disease and transplant clinics) were more likely to believe a biobank is very important (P=0.004) and were more comfortable having genetic information from their blood and tissues used for research, provided no identifying information was associated with it (P=0.01). These participants also indicated they would be more strongly supportive of a biobank if the research might benefit their family in the future (P <0.001), if the biobank was only collecting leftover blood and no extra blood tests were required (P=0.006), and if personally identifying information was not included (P=0.004) ( Table 4 ).
Clinicians versus others
Non-clinicians included patients and their spouse or family members, other hospital visitors and most ethics committee members. More non-clinicians believe biobanking is very important (P=0.007). There were no significant differences between the groups in factors that might otherwise modify their support (Table 5 ).
Ethics committee members versus others
Compared with other participants, ethics committee members considered a perioperative biobank was less important (P=0.003). Ethics committee members were also less comfortable with de-identified genetic information from blood and tissues being used for research (P=0.016) ( Table 6 ).
Participant demographics
Participants who were uncomfortable with participating in genetic research tended to be younger (P=0.019) and were less likely to support research if prior written consent was not obtained (Table 7) . 
Discussion
This survey addresses key aspects of feasibility and appropriateness of developing a large-scale, de-identified, perioperative biobank with opt-out consent. The majority of questionnaires were distributed to patients and staff associated with surgery and community members more likely to need surgical care in the future. To capture the opinion of the hospital community more broadly, we also surveyed the opinions of family members of patients, hospital visitors, clinicians, and members of the hospital ethics committee. To include the opinions of those with potentially greater concern regarding health information privacy, we included patients and visitors in the infectious diseases (e.g. human immunodeficiency and hepatitis virus infections) clinic and in the transplant clinic (e.g. genetic conditions and chronic medical conditions). Our study had an incomplete response rate; 84% of distributed questionnaires were returned. Also taking into consideration the documented refusals to participate, the response rate was 69%. It is possible that non-responders hold different opinions to our study participants, but given the high response rate and the inclusion of a broad range of members of the hospital community, we believe our results are representative of the opinion of the hospital community as a whole, and are thus generalisable. The overwhelming majority of patients and the hospital community support biobanking and genomic research and are comfortable with de-identified samples being collected without specific consent, provided future projects are approved by an ethics committee and researchers aim to optimise privacy for participants. This is in spite of very few participants having a known genetic condition or a prior need for genetic testing or counselling. Primary reasons for this support are altruistic and include a desire to support advances in future medical care. This population was especially supportive of future genomic research focusing on the causes and treatments for surgical conditions or recovery from trauma.
Privacy of personal health information is a concern to the community. Support for genomic research and biobanking would be enhanced if biobank samples and records did not contain personally identifying (or re-identifiable) information. The hospital and outpatient community is comfortable to be included in a genomic biobank without being asked for prior written consent if their privacy is enhanced by such a model. It was interesting to find that patient and community members are more supportive of a perioperative biobank when compared with ethics committee members. While this discordance may be due to a lower awareness or concern for privacy in members of the general patient community, even community members expected to have a high degree of personal concern for health privacy (those with infectious and genetic diseases), are more supportive. Responsibilities of a hospital ethics committee include making ethical determinations regarding human research at a hospital (or hospital network), to consider the scientific value and potential risks, and to respect the patient community's interests of autonomy and privacy. A consensus approach is generally applied, and therefore while individual opinions of committee members do not necessarily have to be the same as the average opinion of the hospital patient community the balance and overall opinion of the ethics committee should reflect the values and wishes of the wider community. We found that significant difference existed between the opinions of ethics committee members and others, in that ethics committee members consider a perioperative biobank to be less important, and they were less comfortable with de-identified genetic information from blood and tissue samples being used for research. However, the response rate from ethics committee members was relatively low, and the findings may therefore not truly represent the overall views of all members of that committee.
The vast majority of participants believe researchers should be able to store and analyse leftover blood for genomic research 14 . In fact, just over half assumed this might already occur. The support of community members with chronic medical and surgical conditions is higher if a biobank is developed from leftover blood rather than from additional blood samples, which is not surprising given these participants already have a burden of blood testing as part of their medical treatment.
Limitations
There are some limitations of this study. We made numerous statistical comparisons with resultant P values; some statistically significant (unadjusted P value <0.05) findings may be spurious because of type I error. Extrapolating findings from survey research to broader populations is dependent on representative sampling and a high response rate.
Conclusion
In conclusion, there is strong hospital patient and community support for a de-identified perioperative biobank and for genomics research. We believe this study demonstrates adequately that there is no likely reason to think members of the wider hospital community would not consent to participate in a large-scale, de-identified, perioperative genomic biobank in the future, which satisfies a key condition for the ethical use of an opt-out approach to consent in Australian medical research, as stipulated by the National Health and Medical Research Council.
